Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells. Exp Mol Pathol 2006;80:171-6.Zhou T, Zhang Y, Sun G, et al. Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells. Exp ...
This antibody was developed for use in flow cytometry. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing ...
This antibody was developed for use in flow cytometry. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been perform...
Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells. Experimental and molecular pathology 80, 171-6 (2006).Tong Zhou,Yanyun Zhang,Guizhi Sun,Yumei Zhang,Dongqing Zhang,Yapeng Zhao,Nan Chen.  Anti-P-selectin lectin-EGF domain ...
Zhou T,Zhang Y,Sun G,et al.Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells.Experimental and Molecular Pathology. 2006Zhou T, Zhang Y, Sun G, Zhang Y, Zhang D, Zhao Y, et al. Anti-P-selectin lectin-EGF domain monoclonal ...
This antibody was developed for use in flow cytometry. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing ...
This antibody was developed for use in flow cytometry. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been perfo...
Blockage of the Epidermal Growth Factor Receptor by a monoclonal antibody significantly reduced the effectiveness of scFv425-sTRAIL in activated hepatic stellate cells, while a reduced effectivity was also observed after inhibition of the caspase pathway.Conclusion Evidence is presented for the successful...
This antibody was developed for use in flow cytometry. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been perf...